Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
kytx · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$33.00
Consensus
$30.75
+311.6% upside
Low
$25.00
Median: $32.5 · Last Close: $7.47
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$30.75
311.6% upside
High Target
$33
341.8%
Low Target
$25
234.7%
Current Price
$7.47
as of today
Based on analyst price targets, the KYTX stock price prediction for the next 12 months ranges from $25 to $33. The consensus KYTX price forecast of $30.75 implies 311.6% upside from the current price of $7.47.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.10 | ↓ 5.00% |
1-day model range: $7.04–$7.15. Peak: $7.15 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -63.7% |
| 2029 | $2 | -69.2% |
| 2030 | $2 | -71.8% |
| 2031 | — | -73.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KYTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-04-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-16 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-12-04 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-10-30 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-08-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kyverna Therapeutics, Inc. (KYTX) stock. Of the recent 19 rating actions, 1 were upgrades and 0 were downgrades. 4 analysts currently cover KYTX.
Analyst Recommendation Trends
KYTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$13M
↓ 76.5% YoY
Revenue Next Year
$18M
↑ 40.3% YoY
EPS This Year
$-2.87
EPS Next Year
$-2.94
↑ 2.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast KYTX EPS of $-2.87 for the current fiscal year, based on estimates from 5 analysts. The KYTX revenue forecast is $13M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KYTX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KYTX price target is $30.75 (+311.6% upside), with an analyst consensus of Buy.
The KYTX short-term stock prediction for tomorrow is $7.10 (-5.00%). The KYTX stock price prediction for 2027 estimates an average of $4. The KYTX stock prediction for 2030 projects a range of $2–$2.
Kyverna Therapeutics, Inc. trades on NASDAQ under the ticker KYTX. The KYTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
KYTX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month KYTX price target is $30.75, with a high forecast of $33.00 and a low of $25.00. The median price target is shown in the chart above when available. This implies +311.6% potential upside from the current price of $7.47.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.